Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo

ARAI Wataru; HOSOYA Yoshinori; HARUTA Hidenori; KURASHINA Kentaro; SAITO Shin; HIRASHIMA Yuuki; YOKOYAMA Taku; ZUIKI Toru; SAKUMA Kazuya; HYODO Masanobu; YASUDA Yoshikazu; NAGAI Hideo; SHIRASAKA Tetsuhiko

Art

J-GLOBAL ID：200902236746367118 Reference number：09A0070900

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo

S-1での隔日vs連日治療の比較 in vitroおよびin vivoでの胃癌細胞株の腫瘍増殖阻害および毒性減少の評価

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=09A0070900&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0070900&from=J-GLOBAL&jstjournalNo=L3966A") }}

Author (13)： , , , , , , , , , , , ,
Material：
Volume： 13 Issue： 6 Page： 515-520 Publication year： Dec. 2008
JST Material Number： L3966A ISSN： 1341-9625 Document type： Article
Article type：原著論文 Country of issue： Germany, Federal Republic of (DEU) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0070900&from=J-GLOBAL&jstjournalNo=L3966A") }}

Basic research of antitumor(=antineoplastic)drugs

Reference (26)：

SHIRASAKA, T. Development of a novel form of 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs. 1996, 7, 548-557
SHIRASKA, T. Conceptual changes in cancer chemotherapy : from an oral fluoropyrimidene prodrug, UFT, to a novel oral fluoropyrimidine prodrug, S-1, and low-dose FP therapy in Japan. Invest New Drugs. 2000, 18, 315-329
TATSUMI, K. Inhibitory effects of pyrimidine, barbituric acid and pyrimidine derivatives on 5-fluorouracil degradation in rat liver extracts. Jpn J Cancer Res. 1987, 78, 748-755
SHIRASAKA, T. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res. 1993, 53, 4004-4009
SAKATA, Y. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer. 1998, 34, 1715-1720

ｍore...

, , , , , , , ,

Return to Previous Page